Remove 2026 Remove Bioethics Remove Compounding
article thumbnail

Bayer Pharmaceuticals accelerates innovations for patients

LifeProNow

The estimated compounded annual growth rate is more than 26 percent reaching $1.36 billion in sales by 2026. Bayer works on leveraging all the possibilities of the technologies while fully integrating all regulatory and bioethical requirements.”

Bioethics 130